NYU gets new way to monitor asbestos-linked cancer
The New York University have developed the use of fujirebio diagnostics’ mesomark test for use to monitor asbestos-linked cancer. You can be sure that there is a new light shining on the path of mesothelioma patients. Mesothelioma patients should begin to feel happy about this resent development. The results of the study of the New York University have been validated in the use of the vitro test for use to monitor mesothelioma cancers.
This was developed by Fujirebio Diagnostis, Inc. This way is very effective in the fact that it measures the blood protein and then gives a change in the blood protein when there is the presence of disease. This method have been used widely by mesothelioma doctors, and it has worked well enough.
This method has been approved by the U.S. Food & Drug Administration (FDA) under the Humanitarian Device Exemption (HDE) program on January 24, 2007. This approval gave rise to the use of this mesothelioma diagnosis for the identification of mesothelioma cancers. It became very widely used over the years, and it has served well. Asbestos-linked cancer
This method is used to determine the reoccurrence of the disease in mesothelioma patients after undergoing surgery, radiation and maybe chemotherapy. Of course mesothelioma doctors must take such measures so that there won’t be a reoccurrence of the disease. In a case where there is reoccurrence, patients hardly survive because they can’t undergo such integrative procedures the second time.
Presently, over 100 million people in the world have been exposed to this substance called asbestos, and they come down with this mesothelioma cancer in different times. Mesothelioma diagnosis is usually difficult to come by, but under series of different ways, with consistency, you will discover that it is possible.
The exposure of these people to asbestos was as a result of their profession, and others unknowingly. Those who do not know where they got it will have a problem of filing a law suit against the users, but that is not the main point. The main point is you are on your way to death, unless you carry out good integrative and decisive mesothelioma treatments.